Following the takeover Takada will join the ranks of the world’s top 10 drugmakers and will gain expertise in rare diseases, at the cost of a mountain-load of debt. On Wednesday, shareholders of Takeda Pharmaceutical approved the $59 billion takeover… Read More ›